The University of Chicago Header Logo

Connection

Caner Saygin to Rituximab

Back to Details
This is a "connection" page, showing publications Caner Saygin has written about Rituximab.
Caner Saygin
Connection Strength
0.817
Rituximab
  1. Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia. Leuk Res. 2020 02; 89:106297.
    View in: PubMed
    Score: 0.675
  2. Impact of comorbidities on outcomes of elderly patients with diffuse large B-cell lymphoma. Am J Hematol. 2017 Oct; 92(10):989-996.
    View in: PubMed
    Score: 0.142
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.